SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Meta Platforms is surging as investors react to reports that the company plans to monetize its massive AI infrastructure by selling excess compute capacity to external customers. While the news triggered a sharp sell-off in smaller neocloud and semiconductor peers due to fears of increased competition, the broader community is debating whether this initiative is a strategic pivot to boost ROI or a sign of an overbuilt AI infrastructure market.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, Peter Salanki, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeave is facing significant volatility as investors react to reports that Meta is exploring a cloud business to monetize its excess AI compute capacity. While some market participants fear this signals increased competition and potential oversupply, others view the pullback as an overreaction, emphasizing that CoreWeave's long-term infrastructure contracts remain robust and that underlying AI demand remains tightly supply-constrained.

Jack in the Box, Inc. engages in the provision of developing, operating, and franchising a chain of quick-service and fast-casual restaurants. It operates through the Jack in the Box and Del Taco segments. The Jack in the Box segment offers a selection of distinctive products including classic burgers and other product lines such as Buttery Jack Burgers. The company was founded by Robert Oscar Peterson in 1951 and is headquartered in San Diego, CA.

Jack In The Box, Inc.

Jack in the Box is trending as retail traders target the stock for a potential short squeeze, citing its significantly small float and high short interest as key drivers for volatility. The community is actively comparing the setup to past high-profile squeeze plays, fueling intense debate over whether the company's turnaround plan and debt refinancing efforts will fuel a rally or if the bearish sentiment will prevail.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X ETF

Direxion Daily Semiconductor Bull 3X Shares

SOXL is currently experiencing high volatility as investors weigh the semiconductor sector's rapid growth against recent profit-taking and broader market rotation. Community discussions are heavily split between bullish traders viewing the current pullback as a prime buying opportunity and skeptical voices warning of a potential bubble collapse.

Tempus AI, Inc. is a healthcare technology company, which engages in bringing artificial intelligence and machine learning to healthcare. It focuses on building platforms for oncology, neuropsychiatry, cardiology, infectious disease, and radiology. The company was founded by Eric Paul Lefkofsky in August 2015 and is headquartered in Chicago, IL.

Tempus AI Inc. - Ordinary Shares - Class A

Tempus AI Inc

Tempus AI is experiencing significant market interest driven by recent FDA approvals for its tumor-only diagnostic platform and strategic partnerships, which have bolstered the narrative of the company as an emerging infrastructure leader in precision medicine. While community members debate the stock's high short interest and institutional accumulation, sentiment remains sharply divided between those betting on long-term data-moat potential and those skeptical of recent technical volatility.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebius Group stock is facing significant downward pressure following reports that Meta Platforms plans to develop its own cloud business to monetize excess AI compute capacity. Investors are actively debating whether this news signifies a structural threat to the neocloud business model or if it is merely a market overreaction that ignores Nebius's existing multi-billion dollar capacity agreements and the broader, supply-constrained reality of the AI infrastructure sector.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Cloud Memory Business Unit (CMBU), Core Data Center Business Unit (CDBU), Mobile and Client Business Unit (MCBU), and Automotive and Embedded Business Unit (AEBU). The CMBU segment focuses on memory solutions for large hyperscale cloud customers and High-Bandwidth Memory for all data center customers. The CDBU segment is involved in memory solutions for mid-tier cloud, enterprise, and OEM data center customers and storage solutions for all data center customers. The MCBU segment focuses on memory and storage solutions for the mobile and client segments. The AEBU segment is involved in memory and storage solutions for the automotive, industrial, and consumer segments. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology is experiencing sharp volatility as investors digest reports of potential excess compute capacity in the AI ecosystem and broader sector rotation, leading to a significant pullback from recent highs. While some market participants are expressing concern over high-level valuation and short-term news catalysts, a vocal segment of the community remains focused on strong long-term fundamentals, persistent memory shortages, and strategic supply agreements as reasons to treat the decline as an accumulation opportunity.

Roundhill ETF Trust - Roundhill Memory ETF

DRAM is experiencing high volatility as investors weigh the structural memory supercycle against concerns about cyclical supply gluts and international regulatory headwinds. The community remains sharply divided, with bulls pointing to robust demand from AI hyperscalers and upcoming SK Hynix listings as catalysts for a rebound, while bears warn of potential demand destruction and the risks of a crowded, speculative trade.

Constellation Energy Corp. engages in the generation, supply, and marketing of clean electricity, and renewable energy products and solutions. The firm also offers wholesale energy, retail products and services. It operates under the following geographical segments: Mid-Atlantic, Midwest, New York, Electric Reliability Council of Texas (ERCOT), and Other Power Regions Segment. The company was founded in 1960 and is headquartered in Baltimore, MD.

Constellation Energy Corporation

Constellation Energy is currently drawing significant investor interest as a core play on the explosive AI-driven electricity demand cycle, with community members actively debating its valuation following a sharp recent pullback. Despite volatility stemming from structural share lock-up expirations and sector-wide sentiment shifts, the consensus among long-term holders remains focused on its unmatched nuclear fleet and strategic, long-term power agreements with major tech hyperscalers.

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

IREN Limited is experiencing intense selling pressure and market skepticism as investors react to reports of major hyperscalers potentially monetizing excess compute capacity, which has sparked fears of increased supply and sector-wide competition. While the community remains divided, many investors are closely tracking leadership's capital allocation and the urgent need for concrete contract announcements to validate the company's long-term infrastructure and power-centric business model.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

NTRA & Aveta Partner to Advance MRD-Guided Trial in Head & Neck Cancer

Natera's Aveta partnership brings Signatera into a global Phase 3 head and neck cancer trial to assess MRD and treatment response.

Natera Partners With Aveta Biomics On Phase 3 Head And Neck Cancer Trial

(RTTNews) - Natera, Inc. (NTRA), a clinical genetic testing company, and Aveta Biomics, Inc., an immuno-oncology company, on Monday announced a partnership to support AVTA 30-01, Aveta's Phase 3 trial evaluating its immunotherapy candidate APG-157 in patients with locally advance...

Natera and Aveta Biomics Announce Strategic Partnership Supporting Global Phase 3 Registrational Trial of APG-157 in Head and Neck Cancer

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, and Aveta Biomics, Inc., a clinical-stage immuno-oncology company advancing first-in-class oral immunotherapies for solid tumors, today announced a strategic partnership supporting AVTA 30-01, Avetas global Phase...

U.S. Supreme Court Rejects CareDxA's Appeal in Natera, Inc. (NTRA) False-advertising Dispute

U.S. Supreme Court Rejects CareDxA's Appeal in Natera, Inc. (NTRA) False-advertising Dispute...

NTRA's Signatera Secures PMDA Approval for MRD Testing in CRC in Japan

Natera's Signatera gains Japan PMDA approval for CRC, marking the country's first approved MRD test and advancing its global expansion.

Natera (NTRA) Stock Jumps 10.7%: Will It Continue to Soar?

Natera (NTRA) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Natera and Eledon Announce Strategic Partnership for Prospera Monitoring in Planned Phase 3 Kidney Transplant Trial

Natera, Inc. (Nasdaq: NTRA), a global leader in cell-free DNA and precision medicine, and Eledon Pharmaceuticals, Inc. (Nasdaq: ELDN), a clinical stage biotechnology company developing immune-modulating therapies for the management and treatment of life-threatening conditions, today announced a...

Natera Secures Landmark Japan Nod For Signatera In Colorectal Cancer

Natera won Japan approval for Signatera in colorectal cancer, paving the way for a commercial launch by 2026.read more...

Signatera Receives Regulatory Approval in Japan for Colorectal Cancer

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced that Signatera has received regulatory approval from Japans Pharmaceuticals and Medical Devices Agency (PMDA). This approval supports the use of Signatera for patients with colorectal cancer (CRC...

EXEL Down on Colorectal Cancer Study Data on Zanzalintinib 

Exelixis falls after STELLAR-303 misses statistical significance in overall survival for a key colorectal cancer subgroup, raising approval uncertainty.

Natera, Inc. is a diagnostics company, which engages in the discovery, development, and commercialization of genetic testing services. It provides Panorama non-invasive prenatal test (NIPT), Vistara, horizon carrier screening (HCS), spectrum pre-implantation genetic screening and spectrum pre-implantation genetic diagnosis, Anora products of conception (POC) and non-invasive paternity testing (PAT). The company was founded by Matthew Rabinowitz and Jonathan Sheena in November 2003 and is headquartered in Austin, TX.

Natera Inc

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Earnings

Fundamentals

Info

NTRANatera Inc

Latest NTRA News